You searched for "career"

1215 results found

OCT changes after occlusion therapy in amblyopic and fellow eyes

This study compared optical coherence tomography (OCT) data of fellow and amblyopic eyes, and reported OCT changes after long-term electronically monitored occlusion therapy. The study recruited 30 patients with mean age of 16.7 ±11.2 years (range 5.1–44.7 years): 53% males....

Virtual ophthalmic conferences: learnings from the Covid-19 pandemic

The Covid-19 pandemic was the catalyst for a number of paradigm shifts in numerous industries. The demand for proxies that follow social distancing measures created a hotbed for digital solutions and transitioned these to social convention. In the aftermath, the...

Orbis and FedEx team up on three-week training for Eye Care Professionals in Vietnam

This is the first surgical project for the Orbis Flying Eye Hospital in three years.

Lessons from ARVO 2025

Conferences abroad are wonderful indeed. You get to escape from the crushing grind of reality at the NHS coalface for a few days and learn about the cutting edge of your subspecialty. By the end of these events, I actually...

The work of RNIB and ECLOs

With more than 2,000,000 people in the UK living with some degree of sight loss and over 300,000 registered as blind or partially sighted, it is important for anyone living with sight loss to know they’re not alone. At what...

Brain tumours in adults: the essentials for an ophthalmologist

The author provides a review of the common intracranial tumours in adults (other than pituitaries) which may present to an ophthalmologist. Primary malignant brain tumours comprise 3% of adult cancers but with an ageing population such tumours are becoming more...

Enucleation refusal for retinoblastoma

Retinoblastoma is the most common eye cancer in childhood, with enucleation rarely being the only lifesaving surgical option, especially where evidence of extraocular spread is apparent. This study sought to survey a global pool of eye care professionals with regards...

MicroRNA inhibits corneal neovascularisation

MicroRNAs (miR) are small non-coding RNA that target mRNA for destruction. MiR target about 30% of the protein coding genes and fine tune their expression. MiR have been shown to be involved in several cellular processes including cell cycle, tissue...

The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy

The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...

Online retinoblastoma surveillance tool

Given the vision and life-threatening course of retinoblastoma (RB), it has become a significant heritable childhood cancer to screen for. To recommend surveillance, risk must be estimated and genetic testing plays a vital role. However, genetic tests vary based on...

Second primary tumours after sebaceous carcinoma

This is a study investigating the risk of developing a second primary malignancy in patients previously diagnosed with eyelid sebaceous cell carcinoma. The records of 559 patients who were diagnosed with sebaceous cell carcinoma between 2000 and 2016 were reviewed,...

Using a tumour registry to investigate optic nerve gliomas

This study is a retrospective comparative analysis. Patients with optic nerve glioma and pilocytic astrocytoma were identified through the Surveillance, Epidemiology and End Results (SEER) cancer registry covering a 42-year period using standardised codes. The following data was extracted: basic...